Tenofovir 1% vaginal gel for prevention of HIV-1 infection...

The Lancet Infectious Diseases 2018 / 11 Vol. 18; Iss. 11

Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial

Delany-Moretlwe, Sinead, Lombard, Carl, Baron, Deborah, Bekker, Linda-Gail, Nkala, Busi, Ahmed, Khatija, Sebe, Modulakgotla, Brumskine, William, Nchabeleng, Maposhane, Palanee-Philips, Thesla, Ntshang
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(18)30428-6
Date:
November, 2018
File:
PDF, 352 KB
english, 2018
Conversion to is in progress
Conversion to is failed